Related references
Note: Only part of the references are listed.The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom
Daryl C. Yang et al.
NEUROTOXICITY RESEARCH (2017)
Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
Jose Maria Gutierrez et al.
TOXINS (2017)
Venoms of Micrurus coral snakes: Evolutionary trends in compositional patterns emerging from proteomic analyses
Bruno Lomonte et al.
TOXICON (2016)
Comparison of F(ab′)2 versus Fab antivenom for pit viper envenomation: A prospective, blinded, multicenter, randomized clinical trial
Sean P. Bush et al.
CLINICAL TOXICOLOGY (2015)
Eastern coral snake Micrurus fulvius venom toxicity in mice is mainly determined by neurotoxic phospholipases A2
Irene Vergara et al.
JOURNAL OF PROTEOMICS (2014)
The Lymphatic System Plays a Major Role in the Intravenous and Subcutaneous Pharmacokinetics of Trastuzumab in Rats
Annette M. Dahlberg et al.
MOLECULAR PHARMACEUTICS (2014)
Biochemical characterization of the venom of the coral snake Micrurus tener and comparative biological activities in the mouse and a reptile model
Melisa Benard-Valle et al.
TOXICON (2014)
Review of Eastern coral snake (Micrurus fulvius fulvius) exposures managed by the Florida Poison Information Center Network: 1998-2010
A. Wood et al.
CLINICAL TOXICOLOGY (2013)
Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American Rattlesnake bite patients
Sean P. Bush et al.
TOXICON (2013)
Isolation, characterization, cloning and expression of an alpha-neurotoxin from the venom of the Mexican coral snake Micrurus laticollaris (Squamata: Elapidae)
Alejandro Carbajal-Saucedo et al.
TOXICON (2013)
Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab′)2 antivenoms
Leslie V. Boyer et al.
TOXICON (2013)
Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab ')(2), IgG and IgG(T) fragments from hyper immune equine plasma
H. Vazquez et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings
Leslie V. Boyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lymphatic absorption of subcutaneously administered proteins: Influence of different injection sites on the absorption of darbepoetin alfa using a sheep model
Jagannath Kota et al.
DRUG METABOLISM AND DISPOSITION (2007)
Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin
Sukyung Woo et al.
DRUG METABOLISM AND DISPOSITION (2007)
Pharmacokinetics of a F(ab′)2 scorpion antivenom in healthy human volunteers
H Vázquez et al.
TOXICON (2005)
Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy
MN Krifi et al.
TOXICON (2005)
Modelling Tityus scorpion venom and antivenom pharmacokinetics.: Evidence of active immunoglobulin G's F(ab′)2 extrusion mechanism from blood to tissues
C Sevcik et al.
TOXICON (2004)
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation
JM Gutierrez et al.
CLINICAL PHARMACOKINETICS (2003)
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
CJH Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies
SA Seifert et al.
ANNALS OF EMERGENCY MEDICINE (2001)
Share Paper
